Biogen Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| LLY | Eli Lilly and | Outperform |
16
|
$807.43 | $636.99 | 8.68% | 9 | $727.01B |
| NOVO B | Novo Nordisk A/S | Outperform |
12
|
kr928.80 | kr696.07 | 3.63% | 14 | kr4.12T |
| JNJ | Johnson & Johnson | Outperform |
9
|
$146.97 | $174.55 | 15.67% | 3 | $353.71B |
| MRK | Merck | Outperform |
2
|
$129.49 | $130.51 | 11.21% | 11 | $327.97B |
| ABBV | AbbVie | Outperform |
9
|
$157.06 | $178.42 | 16.20% | 11 | $277.35B |
| AZN | AstraZeneca PLC | Outperform |
17
|
£122.96 | £165.99 | 37.18% | 16 | £190.62B |
| NOVN | Novartis | Hold |
10
|
CHF91.74 | CHF105.00 | 17.31% | 9 | CHF187.19B |
| ROG | Roche Holding | Hold |
16
|
CHF230.40 | CHF307.83 | 18.27% | 9 | CHF185.99B |
| DHR | Danaher | Outperform |
10
|
$262.78 | $260.33 | 3.67% | 4 | $194.64B |
| AMGN | Amgen | Outperform |
4
|
$305.84 | $303.65 | 5.38% | 8 | $164.06B |
| PFE | Pfizer | Outperform |
2
|
$28.88 | $32.87 | 5.61% | 6 | $163.65B |
| SAN | Sanofi | Outperform |
16
|
89.52€ | 102.80€ | 21.76% | 9 | 111.91€B |
| VRTX | Vertex Pharmaceuticals Inc | Outperform |
12
|
$456.95 | $457.59 | 0.45% | 11 | $117.92B |
| MDT | Medtronic | Outperform |
11
|
$82.29 | $92.47 | 16.66% | 9 | $107.91B |
| REGN | Regeneron Pharmaceuticals | Outperform |
2
|
$985.02 | $961.26 | 6.60% | 8 | $106.27B |
| GSK | GSK | Outperform |
12
|
£17.75 | £17.30 | 12.39% | 12 | £72.36B |
| CSL | CSL | Outperform |
12
|
$280.92 | $205.51 | -26.86% | 5 | $135.76B |
| BMY | Bristol-Myers Squibb | Hold |
2
|
$41.24 | $58.15 | 30.94% | 10 | $83.60B |
| GILD | Gilead Sciences Inc | Outperform |
11
|
$65.68 | $87.82 | 21.80% | 14 | $81.83B |
| MRK | Merck KGaA | Outperform |
18
|
167.75€ | 190.06€ | 9.09% | 4 | 72.93€B |
| ZTS | Zoetis | Outperform |
18
|
$170.07 | $220.47 | 27.59% | 5 | $77.60B |
| MRNA | Moderna | Outperform |
16
|
$166.61 | $135.42 | -24.37% | 1 | $63.85B |
| 4502 | Takeda Pharmaceutical Company | Outperform |
5
|
¥4.13k | ¥4.74k | 8.85% | 0 | ¥6.49T |
| DSFIR | DSM-Firmenich | Outperform |
18
|
105.95€ | 114.60€ | 14.20% | 0 | 28.11€B |
| BAYN | Bayer | Hold |
5
|
27.63€ | 45.15€ | 8.58% | 4 | 27.14€B |
| DIM | Sartorius Stedim Biotech | Outperform |
18
|
192.55€ | 254.69€ | 24.64% | 3 | 18.74€B |
| TEVA | Teva Pharmaceutical Industries | Outperform |
12
|
$16.60 | $11.59 | 2.41% | 9 | $18.80B |
| ALNY | Alnylam Pharmaceuticals Inc | Outperform |
7
|
$147.76 | $245.24 | 47.20% | 7 | $18.69B |
| GMAB | Genmab A/S | Outperform |
16
|
kr1.93k | kr2.71k | 36.52% | 14 | kr124.37B |
| 4503 | Astellas Pharma | Outperform |
18
|
¥1.57k | ¥2.64k | 27.75% | 0 | ¥2.81T |
| CE | Celanese | Hold |
13
|
$152.87 | $148.23 | 9.24% | 18 | $16.70B |
| SY1 | Symrise | Outperform |
18
|
105.10€ | 106.97€ | 6.57% | 5 | 14.69€B |
| BMRN | BioMarin Pharmaceutical | Outperform |
10
|
$75.52 | $111.56 | 46.32% | 5 | $14.62B |
| 4523 | Eisai | Outperform |
18
|
¥6.76k | ¥9.58k | 24.19% | 0 | ¥1.97T |
| SRPT | Sarepta Therapeutics | Outperform |
6
|
$123.46 | $158.66 | 34.46% | 6 | $12.51B |
| 500124 | Dr. Reddy's Laboratories | Hold |
18
|
Rp5.86k | Rp5.67k | 3.16% | 25 | Rp977.65B |
| UTHR | United Therapeutics | Outperform |
12
|
$272.88 | $284.08 | 9.94% | 3 | $11.80B |
| SOBI | Swedish Orphan Biovitrum AB (p... | Outperform |
16
|
kr280.20 | kr293.00 | 15.99% | 6 | kr96.39B |
| CRDA | Croda International Plc | Outperform |
18
|
£46.29 | £65.12 | 10.17% | 6 | £6.81B |
| GRF | Grifols | Outperform |
18
|
9.16€ | 18.48€ | 95.41% | 3 | 5.85€B |
| IONS | Ionis Pharmaceuticals | Outperform |
9
|
$37.28 | $55.60 | 60.94% | 3 | $5.76B |
| WCH | Wacker Chemie | Outperform |
17
|
101.45€ | 145.36€ | 23.21% | 9 | 5.00€B |
| CLN | Clariant | Outperform |
18
|
CHF15.01 | CHF16.11 | 6.60% | 6 | CHF4.67B |
| BIOCON | Biocon | Hold |
14
|
Rp319.45 | Rp270.86 | -9.22% | 14 | Rp365.06B |
| PRGO | Perrigo Co PLC | Outperform |
16
|
$27.88 | $44.75 | 43.47% | 0 | $4.19B |
| ALKS | Alkermes | Outperform |
10
|
$24.02 | $33.27 | 33.22% | 3 | $4.11B |
| 4403 | NOF | Buy |
18
|
¥2.00k | ¥7.63k | 41.33% | 0 | ¥505.28B |
| TGTX | TG Therapeutics | Outperform |
9
|
$16.71 | $29.44 | 106.46% | 6 | $2.38B |
| DYN | Dyne Therapeutics | Buy |
5
|
$31.22 | $28.13 | 44.14% | 0 | $2.27B |
| DCPH | Deciphera Pharmaceuticals | Hold |
6
|
$25.51 | $23.40 | 1.92% | 4 | $2.19B |
| 4516 | Nippon Shinyaku | Outperform |
18
|
¥3.52k | ¥8.34k | 44.97% | 0 | ¥261.33B |
| WVE | Wave Life Sciences | Outperform |
6
|
$6.22 | $9.21 | 92.93% | 3 | $688.23M |
| STOK | Stoke Therapeutics | Buy |
4
|
$14.41 | $19.33 | 38.79% | 3 | $604.59M |
| ABUS | Arbutus Biopharma | Outperform |
9
|
$3.29 | $6.34 | 66.57% | 0 | $535.96M |
| FULC | Fulcrum Therapeutics | Outperform |
9
|
$7.21 | $10.21 | 108.04% | 7 | $456.83M |
| AMRN | Amarin | Hold |
8
|
$0.85 | $2.05 | 17.65% | 1 | $378.19M |
| NKTR | Nektar Therapeutics | Hold |
11
|
$1.64 | $2.75 | -2.44% | 2 | $301.14M |
| CHRS | Coherus BioSciences | Outperform |
6
|
$1.91 | $10.86 | 318.85% | 3 | $255.37M |
| PYC | PYC Therapeutics | Buy |
8
|
$0.12 | $0.30 | 183.33% | 1 | $294.90M |
| MTNB | Matinas BioPharma Holdings | Buy |
7
|
$0.17 | $0.65 | 488.24% | 0 | $44.04M |
| ACST | Acasti Pharma | Buy |
0
|
$2.72 | $16.34 | 196.32% | 0 | $26.98M |
| 542934 | Chandra Bhagat Pharma | - |
0
|
Rp116.45 | Rp0.00 | -100.00% | 0 | Rp897.11M |
| ENZN | Enzon Pharmaceuticals | - |
0
|
$0.09 | $16.00 | -100.00% | 0 | $8.48M |
| ACOR | Acorda Therapeutics | - |
5
|
$0.70 | $200.00 | -100.00% | 1 | $0.53M |
| NPHC | Nutra Pharma | - |
0
|
$0.00 | $0.53 | 0.00% | 0 | $0.01M |
| CDXI | Cardax | - |
0
|
$0.00 | $0.00 | 0.00% | 0 | $0.00M |